The Origin of Tumor DNA in Urine of Urogenital Cancer Patients: Local Shedding and Transrenal Excretion.
Autorzy:
Hentschel AE; Amsterdam UMC, Vrije Universiteit Amsterdam, Pathology, Cancer Center Amsterdam, de Boelelaan 1118, 1182 DB Amsterdam, The Netherlands.; Amsterdam UMC, Vrije Universiteit Amsterdam, Urology, Cancer Center Amsterdam, de Boelelaan 1118, 1182 DB Amsterdam, The Netherlands. van den Helder R; Amsterdam UMC, Vrije Universiteit Amsterdam, Pathology, Cancer Center Amsterdam, de Boelelaan 1118, 1182 DB Amsterdam, The Netherlands.; Antoni van Leeuwenhoek/Netherlands Cancer Institute, Gynecologic Oncology, Center of Gynecologic Oncology Amsterdam, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. vanTrommelNE; Antoni van Leeuwenhoek/Netherlands Cancer Institute, Gynecologic Oncology, Center of Gynecologic Oncology Amsterdam, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. van Splunter AP; Amsterdam UMC, Vrije Universiteit Amsterdam, Pathology, Cancer Center Amsterdam, de Boelelaan 1118, 1182 DB Amsterdam, The Netherlands. van Boerdonk RAA; Amsterdam UMC, Vrije Universiteit Amsterdam, Pathology, Cancer Center Amsterdam, de Boelelaan 1118, 1182 DB Amsterdam, The Netherlands. van Gent MDJM; Amsterdam UMC, Location Amsterdam Medical Center, Gynecologic Oncology, Center of Gynecologic Oncology Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Nieuwenhuijzen JA; Amsterdam UMC, Vrije Universiteit Amsterdam, Urology, Cancer Center Amsterdam, de Boelelaan 1118, 1182 DB Amsterdam, The Netherlands. Steenbergen RDM; Amsterdam UMC, Vrije Universiteit Amsterdam, Pathology, Cancer Center Amsterdam, de Boelelaan 1118, 1182 DB Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Jan 31; Vol. 13 (3). Date of Electronic Publication: 2021 Jan 31.
Non-invasive detection of endometrial cancer by DNA methylation analysis in urine.
Autorzy:
van den Helder R; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Pathology, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.; Antoni van Leeuwenhoek/Netherlands Cancer Institute, Center of Gynecologic Oncology Amsterdam, Department of Gynecologic Oncology, Amsterdam, The Netherlands. Wever BMM; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Pathology, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands. vanTrommelNE; Antoni van Leeuwenhoek/Netherlands Cancer Institute, Center of Gynecologic Oncology Amsterdam, Department of Gynecologic Oncology, Amsterdam, The Netherlands. van Splunter AP; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Pathology, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands. Mom CH; Amsterdam UMC, University of Amsterdam, Center of Gynecologic Oncology Amsterdam, Department of Gynecologic Oncology, Cancer Center Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. Kasius JC; Amsterdam UMC, University of Amsterdam, Center of Gynecologic Oncology Amsterdam, Department of Gynecologic Oncology, Cancer Center Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. Bleeker MCG; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Pathology, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands. Steenbergen RDM; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Pathology, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands. .
Pokaż więcej
Źródło:
Clinical epigenetics [Clin Epigenetics] 2020 Nov 03; Vol. 12 (1), pp. 165. Date of Electronic Publication: 2020 Nov 03.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
